MyAverix Finance
F · Healthcare
UCB S.A. UNSP.ADR 1/2 (UNC0)
Biotechnology
UCB S.A. UNSP.ADR 1/2 (UNC0) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-05-21, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for UNC0
UCB S.A. UNSP.ADR 1/2 (UNC0) — FAQ
What is UNC0's P/E ratio?
The price-to-earnings (P/E) ratio for UCB S.A. UNSP.ADR 1/2 (UNC0) is 25.00 (data as of 2026-05-21).
Does UCB S.A. UNSP.ADR 1/2 pay a dividend?
Dividend yield is not available in the current snapshot for UCB S.A. UNSP.ADR 1/2 (UNC0). Check the MyAverix Finance app for the latest dividend data.
What sector is UCB S.A. UNSP.ADR 1/2 in?
UCB S.A. UNSP.ADR 1/2 (UNC0) is classified in the Healthcare sector (Biotechnology industry).
What exchange is UNC0 listed on?
UNC0 is listed on F.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.